A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)
Clinical trial NCT01455701 · COMPLETED
Trial details
- NCT number
- NCT01455701
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-26
- Primary completion
- 2016-07-28
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.